Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga
After a recent fall in profit, Masayoshi Son of SoftBank announced that the Japanese tech investor will look at dramatic cost-cutting. Before he does that, investments in India for calendar year 2022 (CY22) will fall radically, observed sources in the know. Last year, the company had invested around $3.2-3.5 billion in the Indian start-up ecosystem - almost 10 per cent of the total investment the sector received. For CY22, the investments may not even touch $1 billion.
'We are anticipating that the hiring trend will continue to see double-digit growth at least for the current financial year.'
In Budget 2020-21, the Department of Space has been allocated Rs 13,949.09 crore, of which Rs 8,228.63 crore has been earmarked for capital expenditure.
'The coronavirus epidemic highlights the need to start thinking more actively about multilateral coordination, including, but not confined to, health emergencies and climate uncertainties,' says Rathin Roy.
Health economist and advisor to the High-Level Expert Group on Universal Health Care, S Selvaraj says that tackling lack of doctors in India will take time to sort out, but providing free drugs can be done immediately.
In a first-of-its-kind scheme, the Indian Railways has installed a squat machine at the Anand Vihar station and 30 squats in front of it will generate a free platform ticket.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Yoga guru Ramdev, who had said he does not need the Covid vaccine as he has protection of yoga and Ayurveda, on Thursday did a somersault, saying he will soon get the jab and described doctors as 'God's envoys on earth'.
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das.
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products
'It seems the action against Nupur was because the vice president was in Qatar and officials in his secretariat did not want any embarrassment.'
The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.
After a lifetime of showing us what it means to 'act at the top of one's bent and never hit a false note', Mammootty had the good sense, in the third act of his career, to pare down his style, become less mannered, draw directly from life. And getting a performer like that to play characters who seem 'completely dead inside', is, in my view, a betrayal of his legacy, his still-burning ambition, and his still-sharp feelers, observes Sreehari Nair.
The government has also given permission to 20 plants to produce the antiviral drug.
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.
Because it costs a shit-ton of money. Full disclosure: I won't accept a wedding ring that costs Rs 1L or less. But Rs 1L and more seems like a LOT of money. Enough for me to think about better ways to spend it. Stocks? Mutual Funds? SIPs? *GASP* NFTs and Crypto?
While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.
It's time for Indian generic companies to rethink their strategies.
'That is how our machinery operates and sees every prisoner.'
With all major US export-oriented drug manufacturing plants in the country up for inspection in 2022, some estimates peg that at least 20-30 per cent of the new product launches lined up for the US will be subject to on-site inspection by the US Food and Drug Administration (USFDA). The last two years saw limited physical inspections due to travel restrictions during the pandemic. "Pre-Covid, the frequency and number of inspections of manufacturing plants in India by USFDA had increased significantly," analysts from ICICI Securities Research noted. "With growing ANDA filings, especially for complex products. "We expect this trend to return with the environment normalising," analysts from ICICI Securities Research noted.
Keep cover letters under one page long, advises Ajay Singh, head, people services, Quess Corp.
The coronavirus pandemic has taught that viruses cannot be taken lightly, and the unpredictability in emerging scenarios of health have to be respected and addressed, Paul noted.
This import duty exemption would remain in force till October 31 this year.
ICC CEO Manu Sawhney was sent on 'leave' in March after his conduct came under the scanner during an internal investigation by by audit firm PricewaterhouseCoopers.
The proposed merger would likely harm future competition
The Ernst & Young's first ever healthsciences report has predicted global leadership in vaccines and heightened merger and acquisition activity for the domestic bio-pharmaceutical market.
Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.
Prime Minister Narendra Modi on Tuesday met Microsoft co-founder and billionaire philanthropist Bill Gates on the sidelines of the climate summit here and discussed ways to further sustainable development, steps to mitigate climate change and vaccine research. The meeting between Modi and the American business magnate, whose foundation is focusing on fighting the COVID-19 pandemic, took place after the former launched the Initiative for the Resilient Island States (IRIS) for developing infrastructure of small island nations. Prime Minister Modi expressed appreciation for the work being done by the Bill and Melinda Gates Foundation in India, the Ministry of External Affairs (MEA) said in a statement.
The Insurance Regulatory Development Authority of India (Irdai), the regulator for insurance companies, is set to allow the insurers to offer wellness programmes along with life insurance policies that can earn reward points for the policyholders. These reward points can be redeemed for getting a discount during renewal. The insurance regulator has circulated draft guidelines to insurance companies for feedback before issuing the final guidelines, as is the norm.
According to sources in the Bengaluru-headquartered space agency, under the Department of Space, delivery of hardware by the industry was hit due to the lockdown imposed in several States to contain the pandemic in recent months.
It also advised people not to rush for self-medication, blood investigation or radiological imaging like chest X-ray or CT scan without consultation of treating medical officer.
The plea argued that any changes such as inclusion of same sex marriage in the Customary Law are much easier, convenient and practical in marriages which are a type of contract between the partners as they are very remotely based on religion and more generic in nature.
Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.
The Indian Railway Station Development Corporation is now looking to modernise 90 stations across the country.
The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.
Agnipath may be an exercise to address the genuine needs of the armed forces. But overall, it betrays the tendency to use the military and paramilitary for employment generation and shaping a national character, instead of treating them as the professional services they are, notes Shyam G Menon.
Friendships are not merely severed, but built over scuffles. And just about anything can stir things up -- a long-standing feud, a pointless stare, a disrupted moral stance, a fist that ricochets off a face and smacks another face in the near vicinity, observes Sreehari Nair.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances